Edwards Lifesciences
Clinical trials sponsored by Edwards Lifesciences, explained in plain language.
-
Tiny tube vs. open chest: new heart valve battle for Low-Risk patients
Disease control OngoingThis study aims to see if a less invasive procedure to replace a narrowed heart valve is as safe and effective as traditional open-heart surgery for patients who are at low risk for surgery. About 1,000 patients with severe aortic stenosis will be randomly assigned to receive eit…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New device aims to fix leaky heart valves without open surgery
Disease control OngoingThis study is testing a device called the Cardioband FIT System to repair leaky tricuspid heart valves. Doctors will use a catheter (a thin tube) to place the device in the heart without major open-heart surgery. The goal is to see if this approach is safe and can help reduce the…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Decade-Long watch on new heart valve safety
Disease control OngoingThis study is tracking the long-term safety and performance of a specific replacement aortic heart valve in Chinese patients. It will follow up to 250 adults who receive the valve for up to 10 years after their surgery. The main goal is to see how well the valve works over time a…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New heart valve under Real-World scrutiny in global study
Disease control OngoingThis study is collecting real-world information on how well a new replacement mitral heart valve works and how safe it is for patients. It will follow about 500 adults who need their leaky or narrowed mitral valve replaced. The main goals are to see if the valve lasts without cau…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Second chance heart valve: safety under the microscope
Disease control TerminatedThis study aims to monitor the safety of a second, less invasive heart valve procedure for people whose first artificial aortic valve is not working properly. It will follow 50 adults for one month after they receive a new valve inside their old one, tracking serious complication…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New heart device aims to ease pressure for heart failure patients
Disease control OngoingThis early study is testing a new device called the Edwards APTURE Transcatheter Shunt System. It is designed to be implanted in the heart to help relieve pressure for people with symptomatic heart failure. The main goal is to see if the device is safe and works as intended in th…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New device aims to fix failing heart valves without major surgery
Disease control OngoingThis study is testing a new two-part device designed to fix leaky or narrowed pulmonary heart valves in people born with certain heart defects. The device is implanted using a catheter through blood vessels, avoiding open-heart surgery. Researchers want to see if it's safe and ef…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New heart valve device under watch after approval
Disease control OngoingThis study is monitoring the safety and performance of a recently approved heart valve device for people born with specific heart defects. It involves 150 participants who need a new pulmonary valve. The goal is to see how well the device works in real-world use after it received…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New heart valve implant aims to fix severe leak, improve lives
Disease control OngoingThis trial is testing a new device called the Edwards EVOQUE system, which is implanted via a catheter to replace a leaky tricuspid heart valve. It aims to see if this implant, along with standard medication, is safer and more effective than medication alone for patients with sev…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New procedure aims to fix failing heart valves without major surgery
Disease control OngoingThis study is testing a catheter-based procedure to replace failing artificial mitral heart valves. It involves 53 patients who have symptoms like shortness of breath due to their old valve not working properly. Doctors are checking if this less invasive approach is safe and help…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New heart valve study offers hope for those born with complex defects
Disease control OngoingThis study is monitoring the safety and performance of a specific replacement heart valve (the SAPIEN 3) in people born with complex heart defects. It focuses on patients whose existing pulmonary valve is failing, causing blood to leak back or creating a blockage. The goal is to …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New heart valve process put to the test in major safety trial
Disease control OngoingThis study is checking if changes to how replacement heart valves are made and packaged are safe and work well. It involves 777 adults who need to replace a damaged aortic or mitral valve. Researchers will follow participants for up to 5 years to see how the valves hold up and if…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New heart shunt offers hope for stubborn heart failure
Disease control OngoingThis trial is testing a small, implanted device called the APTURE shunt to see if it helps people with certain types of heart failure who still feel poorly despite taking the best available medications. About 100 participants will be randomly assigned to receive either the real s…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New heart shunt offers hope for easing heart failure
Disease control OngoingThis study is testing a new, minimally invasive device called the APTURE shunt in people with heart failure. The device is implanted to create a small opening between heart chambers, aiming to safely reduce high blood pressure in the lungs and heart. Researchers will check if the…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New heart valve procedure tested to fix deadly leaks without major surgery
Disease control OngoingThis study is testing a new device called the EVOQUE system, which is designed to replace a leaky tricuspid heart valve using a catheter inserted through a blood vessel, avoiding open-heart surgery. The trial aims to see if this procedure is safe and effective at reducing severe …
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Heart valve repair showdown: new device challenges standard treatment
Disease control OngoingThis large study is comparing two different devices that repair a leaky mitral heart valve without open-heart surgery. It involves over 1,200 patients who are at high risk for surgery or have heart failure. The main goal is to see if the newer PASCAL device is as safe and effecti…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New heart valve tested as less invasive option for High-Risk patients
Disease control OngoingThis study is testing the safety and performance of a new, less invasive heart valve replacement system. It is for people with severe, symptomatic aortic stenosis who are at intermediate risk for traditional open-heart surgery. The goal is to see if this new device can effectivel…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC